ISO factory supply 99% Lidocaine HCl 73-78-9 CAS NO.73-78-9
- FOB Price: USD: 35.00-35.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Available Specifications:
AAAAA(1-5)Kilogram
- Product Details
Keywords
- Lidocaine HCl
- Lidocaine hydrochloride
- 73-78-9
Quick Details
- ProName: ISO factory supply 99% Lidocaine HCl 7...
- CasNo: 73-78-9
- Molecular Formula: C14h23cln2o
- Appearance: powder
- Application: Pharmaceutical Raw powder
- DeliveryTime: 1-3 days
- PackAge: 1kg/bag, 25kg/drum
- Port: shanghai,beijing,guangzhou, HK
- ProductionCapacity: 10000 Kilogram/Day
- Purity: 99%
- Storage: White crystalline powder
- Transportation: by express, dhl,tnt,ems by air, by sea
- LimitNum: 1 Kilogram
- Related Substances: Related protein shall be not more than...
- Residue on Ignition: 0.08%
- Heavy Metal: <1ppm
- Valid Period: 24 months
- Melting point: 75-79°C(Predicted)
- MW: 270.8
Superiority
Free sample, low freight, fast delivery, payment assurance, 24 hours service,high purity, good effect,good feedback, lead time:1-3 days, payment terms: TT, alibaba, , factory supplier, recruit overseas agents, welcome inquiry.
Details
ISO factory supply 99% Lidocaine HCl 73-78-9
Product Name | Lidocaine HCL |
CAS NO. | 73-78-9 |
Mol. Formula | C14H25ClN2O2 |
MW | 270.8 |
EINECS | 604-158-7 |
Appearance | White crystalline powder |
Purity | 99% |
Lidocaina hydrochlorida is dissolved in water and is generally used as a liquid. Lidocaina is not dissolved in water and is generally used as a cream.
Function of Lidocaine hydrochloride
1. Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.
2.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.
3. Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias if amiodarone is not available or contraindicated.
4. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.